JI-101 blocks the activity of platelet-derived growth factor receptors (PDGFR), which play a crucial role in cell growth, angiogenesis, and tissue. It targets PDGFRβ and VEGFR2.
Molecular Weight
466.33
Molecular Formula
C22H20BrN5O2
Targets
PDGFRβ; VEGFR2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
JI-101 is a PDGFR inhibitor used to study the therapeutic impact of PDGFR targeting in tumors.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
